Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sucrolo is a dietary supplement developed by the Peak Health Foundation, marketed for the maintenance of healthy blood sugar levels and metabolic support. It is part of a suite of Ayurvedic-inspired wellness products that utilize botanical extracts, such as Kriya hops, to influence metabolic pathways. Positioned as a "sugar blocker," the product is intended for consumer use to assist in glucose management. As a nutraceutical, it has not undergone the standard FDA pharmaceutical approval process, and detailed clinical trial data or specific molecular mechanisms of action are not publicly documented in traditional drug pipelines.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sucrolo.